ORAOV1 Activators are a meticulously selected set of chemical compounds that serve to enhance the activity of the ORAOV1 protein through distinct and specialized signaling mechanisms. Forskolin and 8-Bromo-cAMP, for instance, directly increase intracellular levels of cAMP, a pivotal secondary messenger that activates PKA. The activation of PKA is crucial since it can phosphorylate and modulate the activity of various substrates that are part of the ORAOV1 signaling cascade, thereby amplifying the functional role of ORAOV1. Lithium Chloride and Sodium Butyrate, through their respective inhibition of GSK-3β and histone deacetylase, alter gene expression and cellular signaling environments in a manner that indirectly promotes the activity of ORAOV1. This promotion is achieved by enhancing the signaling pathways that ORAOV1 is a part of, thus increasing the overall functional output of ORAOV1.
Furthermore, compounds such as Epigallocatechin Gallate (EGCG) and Piceatannol selectively inhibit kinases that would otherwise negatively regulate the pathways involving ORAOV1, lifting such repression and permitting a higher activity state of ORAOV1. Resveratrol's activation of SIRT1 similarly leads to a cellular milieu that favors ORAOV1 activity through deacetylation of proteins and alteration of gene expression patterns. The actions of Sulforaphane, Ionomycin, and Curcumin also converge on the enhancement of ORAOV1 by modulating the Nrf2 pathway, calcium signaling, and NF-κB pathway, respectively. These pathways, when activated, adjust the cellular environment in such a way that the activity of ORAOV1 is augmented, demonstrating the diverse yet interconnected nature of ORAOV1 activators in upregulating the functional activity of the ORAOV1 protein without the need for direct binding or upregulation of ORAOV1 expression.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase leading to an increase in cyclic AMP (cAMP) levels in the cell. Elevated cAMP levels are known to modulate various signaling pathways, which could enhance ORAOV1 function through downstream effects on transcription factors that increase ORAOV1 activity. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid, a metabolite of vitamin A, binds to retinoic acid receptors (RARs) which regulate gene expression. Activation of RARs can lead to upregulated expression of genes downstream of ORAOV1 signaling pathways, thus indirectly enhancing ORAOV1's functional activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a polyphenol found in green tea with kinase inhibition properties. It may enhance ORAOV1 activity by inhibiting kinases that negatively regulate pathways ORAOV1 is involved in, thus allowing for increased ORAOV1 signaling. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium acts by inhibiting GSK-3β, a negative regulator of the Wnt signaling pathway. Although Wnt is a protein, the inhibition of GSK-3β can lead to activation of signaling pathways that indirectly enhance ORAOV1 activity. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
This cAMP analog is resistant to degradation and activates PKA. PKA can phosphorylate various substrates that may include regulators of ORAOV1, thus enhancing its activity. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
Sulforaphane activates the Nrf2 pathway which can upregulate antioxidant response element (ARE)-driven genes. This activation may lead to an indirect enhancement of ORAOV1 activity if ORAOV1 is involved in oxidative stress responses. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, which can activate calcium-dependent pathways that enhance ORAOV1 function if it is calcium responsive. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate is a histone deacetylase inhibitor that can lead to chromatin remodeling and gene expression changes. This may upregulate pathways that enhance ORAOV1 activity. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin modulates various signaling pathways, including NF-κB, which is involved in inflammatory responses. If ORAOV1 plays a role in such pathways, curcumin could indirectly enhance its activity. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol activates SIRT1, which can deacetylate proteins and influence gene expression. This activation may lead to the enhancement of ORAOV1 activity through modulation of SIRT1-sensitive pathways. | ||||||